• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性溶血性输血反应和迟发性血清学输血反应的发病率趋势。

Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions.

作者信息

Pineda A A, Vamvakas E C, Gorden L D, Winters J L, Moore S B

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

出版信息

Transfusion. 1999 Oct;39(10):1097-103. doi: 10.1046/j.1537-2995.1999.39101097.x.

DOI:10.1046/j.1537-2995.1999.39101097.x
PMID:10532604
Abstract

BACKGROUND

An increasing incidence of delayed hemolytic and delayed serologic transfusion reactions (DHTRs/DSTRs) has been seen at the Mayo Clinic since 1978. Recently, the average length of stay (LOS) for inpatients and the average number of red cell transfusions per inpatient (TPI) decreased, and the albumin and papain technique for RBC antibody detection was replaced by a polyethylene glycol technique. These changes may have affected the incidence of DHTRs/DSTRs.

STUDY DESIGN AND METHODS

The diagnoses of DHTR and DSTR made at the Mayo Clinic from 1993 through 1998 were reviewed. These data were compared with previously published Mayo Clinic data from 1980 through 1992. The LOS for inpatients and the average TPI were also obtained from hospital data.

RESULTS

The incidence of DHTR/DSTR increased from 1 in 1899 in 1980 through 1992 to 1 in 1300 in the 1993 through 1998 period (p < 0.05). Similarly, DSTR increased from 1 in 2990 in 1980 through 1992 to 1 in 1612 in the 1993 through 1998 period (p < 0.05). The incidence of DHTR showed a trend toward decrease, from 1 in 5405 in 1980 through 1992 to 1 in 6715 in 1993 through 1998. No alloantibody specificities were statistically associated with DHTRs in 1993 through 1998, unlike in the 1980 through 1992 period. Moreover, the incidence of Jka antibodies increased in 1993 through 1998, while the incidence of other alloantibodies remained stable. Average LOS and TPI declined by 24.5 percent and 8.8 percent, respectively, between the two periods.

CONCLUSION

Recently, a trend toward a decrease in the incidence of DHTR and a significant increase in DSTRs has occurred at the Mayo Clinic. These changes are most likely due to a combination of factors, including a decrease in average LOS and the adoption of the polyethylene glycol antibody detection system.

摘要

背景

自1978年以来,梅奥诊所延迟性溶血性和延迟性血清学输血反应(DHTRs/DSTRs)的发生率呈上升趋势。最近,住院患者的平均住院时间(LOS)和每位住院患者的红细胞平均输注次数(TPI)有所下降,并且用于红细胞抗体检测的白蛋白和木瓜蛋白酶技术被聚乙二醇技术所取代。这些变化可能影响了DHTRs/DSTRs的发生率。

研究设计与方法

回顾了梅奥诊所1993年至1998年期间做出的DHTR和DSTR诊断。将这些数据与梅奥诊所先前发表的1980年至1992年的数据进行比较。还从医院数据中获取了住院患者的LOS和平均TPI。

结果

DHTR/DSTR的发生率从1980年至1992年的1/1899上升至1993年至1998年期间以的1/1300(p<0.05)。同样,DSTR从1980年至1992年的1/2990上升至1993年至1998年期间的1/1612(p<0.05)。DHTR的发生率呈下降趋势,从1980年至1992年的1/5405降至1993年至1998年的1/6715。与1980年至1992年期间不同,1993年至1998年期间没有同种抗体特异性与DHTR在统计学上相关。此外,1993年至1998年期间Jka抗体的发生率增加,而其他同种抗体的发生率保持稳定。两个时期之间的平均LOS和TPI分别下降了24.5%和8.8%。

结论

最近,梅奥诊所出现了DHTR发生率下降和DSTR显著增加的趋势。这些变化很可能是多种因素共同作用的结果,包括平均LOS的降低和聚乙二醇抗体检测系统的采用。

相似文献

1
Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions.迟发性溶血性输血反应和迟发性血清学输血反应的发病率趋势。
Transfusion. 1999 Oct;39(10):1097-103. doi: 10.1046/j.1537-2995.1999.39101097.x.
2
Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions.聚乙二醇抗球蛋白管与凝胶微柱:对迟发性溶血性输血反应和迟发性血清学输血反应发生率的影响。
Transfusion. 2010 Jul;50(7):1444-52. doi: 10.1111/j.1537-2995.2010.02609.x. Epub 2010 Mar 3.
3
The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis.迟发性溶血性输血反应与迟发性血清学输血反应的鉴别:溶血的发生率及预测因素
Transfusion. 1995 Jan;35(1):26-32. doi: 10.1046/j.1537-2995.1995.35195090655.x.
4
The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance.迟发性血清学和迟发性溶血性输血反应的鉴别:发病率、长期血清学结果及临床意义。
Transfusion. 1990 Oct;30(8):688-93. doi: 10.1046/j.1537-2995.1990.30891020325.x.
5
Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.镰状细胞病患者的同种免疫反应和伴随的迟发性溶血性输血反应的漏诊。
Transfusion. 2019 Jul;59(7):2282-2291. doi: 10.1111/trf.15328. Epub 2019 Apr 25.
6
A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.由E抗原阴性、交叉配血相容的血液引发的伴有多种同种抗体(抗-E、Jka、Dia、Fyb和S)的迟发性溶血性输血反应。
Immunopharmacol Immunotoxicol. 1998 Nov;20(4):531-9. doi: 10.3109/08923979809031514.
7
Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.镰状细胞病患儿的迟发性溶血性输血反应/高溶血综合征
Pediatrics. 2003 Jun;111(6 Pt 1):e661-5. doi: 10.1542/peds.111.6.e661.
8
Management of hemolytic transfusion reactions.溶血性输血反应的处理。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):704-709. doi: 10.1182/hematology.2021000308.
9
Mechanisms responsible for delayed and immediate hemolytic transfusion reactions in a patient with anti-E + Jk(b)+ Di(b) and anti-HLA alloantibodies.一名具有抗 - E + Jk(b)+ Di(b) 和抗 HLA 同种抗体患者发生迟发性和速发性溶血性输血反应的相关机制
Immunopharmacol Immunotoxicol. 2004;26(4):645-52. doi: 10.1081/iph-200042369.
10
[Two serial events of delayed hemolytic transfusion reactions due to different primary immune response-induced irregular antibodies].[由不同的初次免疫反应诱导的不规则抗体引起的两例延迟性溶血性输血反应连续事件]
Rinsho Ketsueki. 2020;61(10):1482-1486. doi: 10.11406/rinketsu.61.1482.

引用本文的文献

1
Harnessing the potential of red blood cells in immunotherapy.挖掘红细胞在免疫治疗中的潜力。
Hum Immunol. 2024 Nov;85(6):111084. doi: 10.1016/j.humimm.2024.111084. Epub 2024 Sep 9.
2
Blood group genotyping in alloimmunized multi-transfused thalassemia patients from Iran.伊朗自身免疫性多输血地中海贫血患者的血型基因定型分析。
Mol Genet Genomic Med. 2021 Jul;9(7):e1701. doi: 10.1002/mgg3.1701. Epub 2021 May 8.
3
Kidd Blood Group Genotyping for Thalassemia Patient in Iran.伊朗地中海贫血患者的基德血型基因分型
Indian J Hematol Blood Transfus. 2020 Jul;36(3):550-555. doi: 10.1007/s12288-020-01283-y. Epub 2020 Apr 29.
4
Alloimmunization in autoimmune hemolytic anemia patient: The differential adsorption approach.自身免疫性溶血性贫血患者的同种免疫:差异吸附法。
Asian J Transfus Sci. 2017 Jan-Jun;11(1):53-57. doi: 10.4103/0973-6247.200782.
5
Pathogenesis and mechanisms of antibody-mediated hemolysis.抗体介导的溶血的发病机制及机制
Transfusion. 2015 Jul;55 Suppl 2(0):S47-58. doi: 10.1111/trf.13147.
6
Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd.亚兹德地区依赖输血的β地中海贫血患者红细胞同种抗体的患病率及特异性
Iran J Ped Hematol Oncol. 2015;5(2):93-9. Epub 2015 Apr 20.
7
Adverse events related to blood transfusion.与输血相关的不良事件。
Indian J Anaesth. 2014 Sep;58(5):543-51. doi: 10.4103/0019-5049.144650.
8
Frequency of unexpected antibody and consideration during transfusion.抗体意外频率和输血时的考虑。
Korean J Anesthesiol. 2012 May;62(5):412-7. doi: 10.4097/kjae.2012.62.5.412. Epub 2012 May 24.
9
Blood-management programs: a clinical and administrative model with program implementation strategies.血液管理项目:一种具有项目实施策略的临床与管理模式。
Perm J. 2009 Winter;13(1):18-28. doi: 10.7812/TPP/08-029.
10
Increased detection of clinically significant antibodies and decreased incidence of delayed haemolytic transfusion reaction with the indirect antiglobulin test potentiated by polyethylene glycol compared to albumin: a Japanese study.与白蛋白相比,聚乙二醇增强的间接抗球蛋白试验可增加临床显著抗体的检出率,并降低迟发性溶血性输血反应的发生率:一项日本研究。
Blood Transfus. 2011 Jul;9(3):311-9. doi: 10.2450/2010.0057-10. Epub 2010 Nov 26.